{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-023189","form_type":"8-K","ticker":"TOI","cik":"0001799191","company_name":"Oncology Institute, Inc.","filed_at":"2024-05-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.167251+00:00","generated_at":"2026-06-02T01:06:15.283378+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Oncology Institute Q1 revenue up 24% to $95M; net loss narrows to $19.9M","bullets":["Revenue of $95M (+24.2% YoY); net loss $19.9M vs $30.0M loss in prior year.","Gross profit $12M (-15.1% YoY); gross margin 12.6% vs 18.5% a year ago.","Adjusted EBITDA loss of $10.9M vs $7.4M loss in prior year quarter.","Signed 7 new value-based contracts; reaffirmed full-year 2024 guidance.","Ended Q1 with 73 clinics, 126 providers; scripts dispensed up 70% YoY."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-023189","json":"https://secwatch.observer/filing/0001628280-24-023189.json","markdown":"https://secwatch.observer/filing/0001628280-24-023189.md","text":"https://secwatch.observer/filing/0001628280-24-023189.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1799191/000162828024023189/0001628280-24-023189-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1799191/000162828024023189/toi-20240514.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T01:06:15.283378+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"05b384deaa3969ac75c82743b6943d4a94d1493f","claim":"Oncology Institute, Inc. reported three months ended March 31, 2024 results: revenue $95 million, net income Net loss of $19.9 million, EPS $(0.22) and $(0.22). Guidance reaffirmed.","evidence_excerpt":"Officer • Hired 7 new providers in the quarter and ended the quarter with 73 clinics and 126 employed providers First Quarter 2024 Financial Highlights • Consolidated revenue of $95 million, an increase of 24.2% from $76 million compared to the prior year quarter • Gross profit of $12 million, a decrease of 15.1% compared to the prior year quarter, and gross margin","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1799191/000162828024023189/0001628280-24-023189-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"three months ended March 31, 2024"},{"label":"Revenue","value":"$95 million"},{"label":"Net income","value":"Net loss of $19.9 million"},{"label":"EPS","value":"$(0.22) and $(0.22)"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}